Q3 above expectations: Net sales, EBITDA and Adj. PAT grew 19%, 32% and 30%, vs. consensus expectation of 17%, 23% and 24%. Volume grew 12% YoY. Gross margin expansion with positive operating leverage absorbed effect of higher A&P; spends (+48% absolute)